QuiVad

Home / Netherlands / Pharming Group N.V.

Pharming Group N.V.

Short position disclosed on September 24, 2026.

Follow

Evolution of the disclosed total

0%2.5%5%7.5%10%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 8.84% on July 30, 2026. The shaded band matches the twelve months of the first chart.

January 23, 2014 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Citadel Advisors LLC1.50%+0.49 ptSeptember 24, 2026
Two Sigma Investments, LP1.28%newSeptember 1, 2026
Capstone Volatility Master (Cayman) Limited0.72%-0.25 ptSeptember 11, 2026
D. E. Shaw & Co., L.P.0.65%newSeptember 18, 2026
Lazard Asset Management LLC0.59%+0.01 ptSeptember 23, 2026
Walleye Capital LLC0.59%newSeptember 22, 2026
Whitebox Advisors LLC0.58%newJune 3, 2026
Spark Investment Management LLC0.52%newJune 19, 2026
AQR Capital Management, LLC0.51%newSeptember 11, 2026
Jupiter Asset Management Ltd.0.51%newSeptember 11, 2026
GSA Capital Partners LLP0.50%newSeptember 23, 2026

In the United States PHGUF (OTC): 12,393,777 shares sold short on September 15, 2026. FINRA names no fund.

On the other side: the funds that hold Pharming Group N.V. Titelia

Follow by RSS

Get the moves on Pharming Group N.V. by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

1147 disclosures on record for this share.
DateFund% of capitalEnd of publication
January 28, 2021WorldQuant, LLC0.61%
January 26, 2021WorldQuant, LLC0.59%
January 26, 2021Citadel Advisors LLC0.47%
January 22, 2021WorldQuant, LLC0.67%
January 21, 2021WorldQuant, LLC0.70%
January 20, 2021WorldQuant, LLC0.69%
January 20, 2021Woodline Partners0.49%
January 15, 2021WorldQuant, LLC0.79%
January 15, 2021Citadel Advisors LLC0.50%
January 14, 2021WorldQuant, LLC0.87%
January 13, 2021Citadel Advisors LLC0.48%
January 12, 2021Citadel Advisors LLC0.51%
January 11, 2021Citadel Advisors LLC0.49%
January 8, 2021Citadel Advisors LLC0.51%
January 6, 2021WorldQuant, LLC0.98%
December 31, 2020WorldQuant, LLC0.86%
December 30, 2020WorldQuant, LLC0.91%
December 29, 2020Citadel Advisors LLC0.47%
December 23, 2020Woodline Partners0.52%
December 23, 2020Citadel Advisors LLC0.51%
December 23, 2020PDT Partners, LLC0.48%
December 22, 2020Woodline Partners0.49%
December 18, 2020WorldQuant, LLC1.00%
December 18, 2020PDT Partners, LLC0.53%
December 16, 2020WorldQuant, LLC0.91%
December 15, 2020WorldQuant, LLC0.88%
December 15, 2020Woodline Partners0.51%
December 10, 2020WorldQuant, LLC0.90%
December 9, 2020WorldQuant, LLC0.89%
December 8, 2020WorldQuant, LLC0.90%
December 3, 2020WorldQuant, LLC0.80%
December 3, 2020Citadel Advisors LLC0.49%
December 2, 2020Great Point Partners, LLC1.86%
December 2, 2020Citadel Advisors LLC0.50%
December 1, 2020WorldQuant, LLC0.73%
December 1, 2020Woodline Partners0.47%
November 27, 2020WorldQuant, LLC0.62%
November 26, 2020Voleon Capital Management LP0.18%
November 25, 2020Voleon Capital Management LP0.69%
November 24, 2020Voleon Capital Management LP0.78%
November 23, 2020WorldQuant, LLC0.52%
November 18, 2020Voleon Capital Management LP0.81%
November 10, 2020Voleon Capital Management LP0.71%
November 2, 2020Voleon Capital Management LP0.67%
October 30, 2020Pictet Asset Management Limited1.40%
October 28, 2020Voleon Capital Management LP0.71%
October 27, 2020Pictet Asset Management Limited1.39%
October 27, 2020Voleon Capital Management LP0.69%
October 26, 2020Pictet Asset Management Limited0.95%
October 26, 2020Woodline Partners0.59%

Download 1147 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the Netherlands

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Pharming Group N.V., source AFM, data as at September 24, 2026, https://www.quivad.com/action/pharming-group-n-v?page=16